After Alzheimer's, Parkinson's is the most common neurodegenerative disease in the world. More than six million people worldwide suffer from it. In this disease, alpha-synuclein proteins form thread-like structures called ...
Nov 15, 2022
0
980
The pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not achieve the goal of slowing clinical decline in participants with early Alzheimer's disease.
Nov 15, 2022
0
2
While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot get vaccinated or in the event that dangerous new strains ...
Nov 14, 2022
0
120
A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective.
Nov 11, 2022
0
55
Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They ...
Nov 8, 2022
0
61
Scientists at Scripps Research have uncovered a critical feature that a promising new class of cancer drugs, known as CELMoDs, needs to be effective.
Nov 3, 2022
0
46
One part of the basal ganglia, known as the nucleus accumbens (NAc), is composed of medium spiny neurons (MSNs). The MSNs, in which the dopamine D1 receptor (D1R) and dopamine D2 receptor (D2R) express, are controlled by ...
Sep 29, 2022
0
13
A deep dive into the proteins and protein activities of human tumors grown in mouse models expands the potential therapeutic pathways to treat medulloblastoma, according to a new study published in the Journal of Proteome ...
Sep 27, 2022
0
31
There are currently no effective treatments for the core symptoms of autism spectrum disorder (ASD), such as difficulties with socializing and communicating. A new study uses a computer-based protein interaction network to ...
Sep 12, 2022
0
291
People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.
Sep 9, 2022
0
17
